L’Orphelin, J.-M. et al. 2024. NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial. Acta Oncologica. 63, 1 (Nov. 2024), 867–877. DOI:https://doi.org/10.2340/1651-226X.2024.40495.